B12 Cyanocobalamin vs Methylcobalamin: What Was Measured
Key takeaways
- Cyanocobalamin and methylcobalamin lose their upper ligand to the same enzyme, MMACHC, and the cell rebuilds both coenzymes from one cobalt(II) intermediate.
- A 1,000 µg cyanocobalamin tablet carries about 19 µg of cyanide, roughly 2% of the molecule by mass, which the body converts to thiocyanate.
- The nearest thing to a head-to-head comparison is a 2021 survey of 42 vegans: median holotranscobalamin 150 pmol/L on cyanocobalamin against 78.5 pmol/L on methylcobalamin.
- In 271 adults over 70 with borderline B12, 1,000 µg of methylcobalamin daily lowered methylmalonic acid and homocysteine at 27 months and left cognitive scores unchanged.
- Cyanocobalamin is the stable, low-cost form used in food fortification. Methylcobalamin degrades under light, which constrains how a product gets made.
Two molecules, one processing step
Cobalamin is a cobalt ion held inside a corrin ring, and the commercial forms differ only in the group above the cobalt: cyano, methyl, hydroxyl or adenosyl. None reaches an enzyme intact. Cells take up cobalamin on transcobalamin, release it from the lysosome, and hand it to a chaperone called MMACHC. Obeid and colleagues mapped the next step in a 2015 review. MMACHC decyanates cyanocobalamin and dealkylates methylcobalamin and adenosylcobalamin. Everything converges on one cobalt(II) intermediate, and the cell rebuilds what it needs from there.
Methylcobalamin arrives finished and gets dismantled anyway.
The review's conclusion is blunt: methylcobalamin and adenosylcobalamin are unlikely to beat cyanocobalamin. That's mechanistic reasoning rather than a trial result, and the difference matters.
What the blood tests actually measure
Serum total B12 rises with either form, and it's blunt, because most of what it counts rides on haptocorrin, which doesn't deliver vitamin to cells. Holotranscobalamin is the better read.
Human comparisons are scarce. The most cited one is a 2021 survey in Experimental and Therapeutic Medicine by Zugravu and colleagues. They kept 42 vegans and sorted them by the supplement they'd chosen for at least a year: 21 on cyanocobalamin, 14 on methylcobalamin, and 7 on algae or kombucha. Those 7 all landed below the 35 pmol/L cutoff. Median holotranscobalamin was 150 pmol/L on cyanocobalamin and 78.5 pmol/L on methylcobalamin, P = 0.001. The methylcobalamin group was taking more per dose, 988 µg against 582 µg, which makes the result awkward to dismiss as underdosing. How often people took a dose predicted holotranscobalamin better than the size of it did.
Forty-two people, no baseline samples, no randomization.
The functional markers
Methylmalonic acid and homocysteine rise when cobalamin runs short, because the two enzymes that need it slow down. They're a closer readout than a serum level.
A trial in Clinical Nutrition in 2017 gave 271 outpatients over 70, all with diabetes and a serum B12 of 150 to 300 pmol/L, either 1,000 µg of methylcobalamin or placebo for 27 months. Methylmalonic acid and homocysteine fell significantly against placebo, at P < 0.0001. The primary outcome, change on the clinical dementia rating scale, didn't differ, and neither did the neuropsychological battery.
The marker moved. The thing it's meant to predict stayed put.
Dose, absorption, and the cyano group
Intrinsic factor mediated uptake tops out around 1.5 µg per meal, so a 2.4 µg RDA is roughly all the active transport can carry at once. Above that, a small fraction crosses by passive diffusion, on the order of 1% of the dose. That's why oral supplements use 500 µg to 1,000 µg instead of 2 µg.
An oral dose at that size rivals an injection. In a 50 patient trial in the American Journal of Clinical Nutrition in 2018, 1,000 µg of oral methylcobalamin daily normalized B12 after gastric bypass surgery, and methylmalonic acid and homocysteine fell as far as they did on intramuscular hydroxocobalamin.
The cyano group deserves its own sentence. It's about 2% of the molecule's mass, so a 1,000 µg tablet delivers roughly 19 µg of cyanide, which the body converts to thiocyanate and clears in urine. Hydroxocobalamin, not cyanocobalamin, is the form used as an antidote in cyanide poisoning.
Stability and what's in the bottle
Cyanocobalamin is the stable one, which is why it's the form in fortified foods and most multivitamins. Obeid's review calls it a stable and inexpensive synthetic form. Methylcobalamin is photosensitive: aerated solutions exposed to ambient light convert to hydroxocobalamin, and the reaction releases formaldehyde. That's an in vitro finding, so it matters for manufacturing more than for biology. A liquid that sits in daylight has to be built around a molecule that degrades, and the 2021 survey found methylcobalamin products dosed anywhere from 1,000 µg to 5,000 µg.
Cheap and stable isn't the same as better. It does explain the shelf.
How strong is the case
The case rests on three claims: it's a coenzyme, it's the form in blood, and it donates methyl groups. The first two are true. The third is where the reasoning loosens, because methylcobalamin carries a methyl group from 5-methyltetrahydrofolate to homocysteine as a cofactor, and the cell makes that cofactor from any cobalamin it takes up.
The counter literature exists. A 2017 narrative review by Paul and Brady in Integrative Medicine argued that methylcobalamin and adenosylcobalamin may suit people with polymorphisms in one carbon metabolism. It's a review without new comparative data. The trials that use methylcobalamin heavily come from Japan and focus on neuropathy at 1,500 µg a day, which is a dose finding as much as a form finding. MTHFR gets invoked most often, and it makes the enzyme that produces 5-methyltetrahydrofolate. Changing folate cycling doesn't make the cobalamin ligand the bottleneck.
What's missing is a randomized comparison at matched dose and frequency, with holotranscobalamin and methylmalonic acid as outcomes. Until it exists, the premium is a bet on a step the cell performs either way.
Frequently asked questions
Is methylcobalamin absorbed better than cyanocobalamin?
Reviews comparing them found no consistent difference in absorption or clinical effect. The one survey reporting a gap was observational, and it favored cyanocobalamin.
Does cyanocobalamin contain cyanide?
About 19 µg per 1,000 µg tablet, roughly 2% of the molecule by mass. The body converts it to thiocyanate and excretes it.
How much B12 does a 1,000 µg tablet deliver?
Roughly 10 µg. Passive diffusion carries about 1% of an oral dose, plus what intrinsic factor can transport.
Does methylcobalamin help if I have an MTHFR variant?
MTHFR changes how folate is cycled. No trial has compared the two cobalamin forms by genotype, so that advice rests on theory.
Which form should a vegan take?
Either, at 500 µg to 1,000 µg daily or a few times a week. Frequency predicted holotranscobalamin better than form did.
---
This article is for general information only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Talk with your health care provider before using vitamin B12 supplements, especially if you take prescription medication.
Sources
- Obeid R, Fedosov SN, Nexo E, Cobalamin coenzyme forms are not likely to be superior to cyano- and hydroxyl-cobalamin, Mol Nutr Food Res 2015
- Zugravu CA et al., Efficacy of supplementation with methylcobalamin and cyanocobalamin in vegan adults, Exp Ther Med 2021
- Randomized placebo controlled trial of vitamin B12 supplementation in older diabetic people with borderline low serum B12, Clin Nutr 2017
- Schijns W et al., Oral compared with intramuscular vitamin B-12 after Roux-en-Y gastric bypass, Am J Clin Nutr 2018
- NIH Office of Dietary Supplements, Vitamin B12 Fact Sheet for Health Professionals